An interventional study of Low carbohydrate diet in Type 1 Diabetes, sponsored by Sheba Medical Center. Recruiting at 1 site in Israel. Open to participants aged 12 Years to 22 Years. Per ClinicalTrials.gov, last updated 2023-05-24.
Sponsored by Sheba Medical Center · Not applicable, Interventional, and Supportive care
The goal of this clinical trial is to compare the effect of low carbohydrate diet versus Mediterranean diet on blood sugar values in adolescents with type 1 diabetes.
The main question aims to answer whether a low carbohydrate diet is as effective as the Mediterranean diet for better glycaemic control in type 1 adolescents.
The investigators are also aiming to check whether low carbohydrate diet is safe and does not elevate cholesterol blood levels and whether the diet is adherable among youth with type 1 diabetes.
Participants with type 1 diabetes wearing a continuous glucose monitor and that will sign an informed consent will be randomly selected for 2 groups. One group will get the Mediterranean diet program and the other will get the low carbohydrate diet program, both for a duration of six months. Each participant will attend a cooking workshop at the beginning of the study. Blood work and stool samples will be taken at the beginning and 3 times through the study periodd. Each participant will attend meetings with the dietician thorough the period of the study.
Background and objective: Improved glycemic control of type 1 diabetes (T1DM), with low rates of adverse events was reported via an online community of children and adults who consume a of low carbohydrate diet (LCD). The investigators aim to compare the effects of a low carbohydrate diet (LCD) with those of a Mediterranean diet on glycemic control, lipid profile, bone metabolites and the microbiome profile in adolescents with type 1 diabetes.
Design A randomized, controlled trail. Families of adolescents in the Diabetes clinic in Edmond and Lily Safra Children's Hospital will be approached and offered to participate in a dietary intervention study. After participants will sign the informed consent, they will randomly be assigned into 2 diet treatment groups, the LCD (n=20) and the Mediterranean diet (n=20). Baseline nutrition teaching session and training and will be conducted for all participants and their parents. Participants will attend visit with the dietician at baseline, 2, 4, 8,12 weeks and will be given a 3-day food dairy to complete twice in that period. Measurements of weight, height, blood pressure, HbA1c, Time in range, number of hypoglycemia, lipid profile, creatinine, bone metabolites will be measured at baseline and 12 and 24 weeks and gut bacteria profile at baseline and at 24 weeks. Personality, quality of life, and socioeconomic questionnaires will be given to children and their parents.
Contribution of the suggested research:
In this research the investigators are aiming to show that LCD is as good as Mediterranean diet with improved glycemic control, safe, and adherable for adolescent with T1D.
10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.
This study's planned enrollment of 40 is below the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.
Browse Diabetes Mellitus studies →Sheba Medical Center is the lead sponsor of 660 studies on the registry; 63 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The LCD will provide 50-80g of carbohydrate per day with no caloric restriction. The planned macronutrient compositions (percentages of the total calories) of the diet were: 15-20% carbohydrate (\<80 g/day), 33% protein and 58% total fat.
Other: Low carbohydrate diet
The MED group was prescribed a moderate-fat MED, rich in vegetables and low in red meat, with poultry and fish preferred to beef and lamb. The primary sources of added fat were 30 to 45 g of olive oil and a handful of nuts (five to seven nuts \<20g) per day. The planned macronutrient compositions of the diet were 40-50% carbohydrate, 25% protein and 35% total fat. The diet is based on the recommendations of Willett and Skerrett
Other: Low carbohydrate diet
In order to maintain equal intensity of treatment, each patient will get a cooking workshop and received a personalized diet regime at baseline, based on the randomly assigned diet. Format and quality of the materials are similar. All diet plans are individualized and matched for energy intake personally . Participants will meet individually with the dietitian for diet instruction and support at week 1,2,4,7,10,12 and thereafter at 24 weeks for a total of seven frontal meetings. Twice during the first 12 weeks the dietician will conduct 10-15-minute motivational telephone calls with all the participants.
Change of time in range (TIR) 70-180 mg/dl after following a LCD or a MD in adolescents with T1DM.
Time spent in range (TIR) 70-180 mg/dl assessed by CGM was downloaded at each visit with the dietician. Severe hypoglycemia was defined as an episode requiring assistance and was confirmed by documentation of a blood glucose value less than 54 mg per deciliter
Time frame: The change of TIR between baseline and after six months
Evaluation of the influence of LCD vs. MD on HbA1c.
Blood test for Hba1c will be taken at baseline and 24 weeks. Insulin dose and glycemic variability will be taken at each visit with the dietician from=n the pump and sensor downloads.
Time frame: The change between baseline and after six months
Assessment of the impact of dietary changes after an LCD vs. MD on gut dysbiosis
Three stool samples will be take from each participant, and kept in -80c until being investigated in a lab
Time frame: The change between baseline and after six months
Assessment of the impact of both diets on bone turnover measures.
Blood samples will be taken from the participants after a 12-hr fast at baseline,12 and 24 weeks. Bone markers: procollagen type 1 amino-terminal propeptide (P1NP) and bone resorption C-terminal telopeptide of type 1 collagen (CTx1) as well as cholesterol, LDL cholesterol, triglyceride and HDL cholesterol.
Time frame: The change of bone turnover at baseline and after six months
Assessment of the impact of dietary changes after an LCD vs. MD on quality of life.
Quality of life questionnaire for type 1 diabetes adolescents will be given at baseline and after 6 months. A higher score reflects a better equality of life.
Time frame: The change between baseline and after six months in the quality of life.
Change in BMI after LCD vs. MD
Measured height and weight will be taken at baseline and after 6 months of intervention in both arms and will be calculated into BMI. The outcome is the change in BMI at baseline and at the end of the intervention.
Time frame: BMI change at baseline and after six months
Change in diet LCD vs. MED
FFQ (food frequency questionnaire) will be given at baseline and after 6 months to both arms, change of micronutrients and macronutrients will be calculated according to the questionnaire
Time frame: Baseline and after six months
Change in LDL cholesterol
Blood test will be taken at baseline and after six months of intervention. Change in LDL cholesterol before and after the diets.
Time frame: Baseline and after 6 months
Documents are hosted by the registry — open the source record to download them.
Plan to share: No
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sheba Medical Center